Kazia Therapeutics-Spon ADRKZIA

13F holders, Q2 2026 (June 30)
35holders +12
17new positions
5sold out
4famous investors
$13.94avg. 13F price*

At the end of Q2 2026, 35 institutions reported holding Kazia Therapeutics-Spon ADR (KZIA) in their 13F filings, up 12 from Q1 2026. 17 opened new positions and 5 sold out. The largest holders were Boxer Capital Management, LLC ($7.9M), Flputnam Investment Management Co. ($5.8M) and Bleichroeder LP ($5.6M). 4 famous investors held it, including Leon Cooperman (0.0% of Omega Advisors (Leon Cooperman)'s portfolio), Steve Cohen (0.0% of Point72 Asset Management's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).

Company
Kazia Therapeutics-Spon ADR
CUSIP
48669G303
Latest filing quarter
Q2 2026

History

Number of 13F holders

010203040 Q2 2025: 10Q2 2025Q3 2025: 11Q3 2025Q4 2025: 22Q4 2025Q1 2026: 23Q1 2026Q2 2026: 35Q2 2026

Total Exit/New Position Q1 2026 → Q2 2026

InstitutionsTotal Value
New Positions17$22.4M
Exits5$2.9M

All 13F filers, Q1 2026 → Q2 2026: 2,320,522 shares bought and 435,054 shares sold, net +1,885,468 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 35 holders

Boxer Capital Management, LLC 0.59% New 560,000 $7.9M
Flputnam Investment Management Co. 0.07% Add +191.3% 414,958 $5.8M
Bleichroeder LP 1.01% No change 400,000 $5.6M
Ikarian Capital, LLC 0.91% New 396,201 $5.6M
Dauntless Investment Group, LLC 8.65% Add +343.7% 354,208 $5.0M
Stonepine Capital Management, LLC 3.70% No change 345,179 $4.9M
Point72 Asset Management 0.00% Add +0.1% 200,300 $2.3M
Ensign Peak Advisors, Inc 0.00% New 110,778 $1.6M
Millennium Management 0.00% New 101,376 $1.4M
UBS Group AG 0.00% Add +482.0% 81,090 $1.1M
J. Goldman & Co LP 0.03% New 68,491 $964K
ADAR1 Capital Management, LLC 0.04% New 61,550 $867K
Jane Street Group, LLC 0.00% New 57,140 $805K
Barclays PLC 0.00% Add +137.5% 56,999 $803K
Susquehanna International Group, LLP 0.00% New 50,616 $713K
Omega Advisors (Leon Cooperman) 0.02% New 50,000 $704K
Westside Investment Management, Inc. 0.09% Reduce -5.6% 47,585 $670K
Morgan Stanley 0.00% Add +4560.6% 46,606 $656K
Marshall Wace, LLP 0.00% New 44,231 $623K
XTX Topco Ltd 0.01% New 31,186 $439K
BNP Paribas Financial Markets 0.00% Add +2683.5% 30,090 $424K
Citadel Advisors 0.00% New 28,509 $401K
Raymond James Financial Inc. 0.00% Add +43.5% 22,599 $318K
Sequoia Financial Advisors, LLC 0.00% Reduce -66.7% 20,003 $282K
Engineers Gate Manager LP 0.00% New 14,975 $211K
Laird Norton Wetherby Trust Company, LLC 0.00% Add +4.0% 12,900 $182K
United Bank 0.02% New 12,851 $181K
Rockefeller Capital Management L.P. 0.00% No change 12,700 $179K
JPMorgan Chase & Co. 0.00% New 2,863 $41K
GAMMA Investing LLC 0.00% Add +22.8% 1,926 $27K
Rhumbline Advisers 0.00% Reduce -7.6% 1,296 $18K
Arax Advisory Partners 0.00% New 87 $1K
Caitong International Asset Management Co., Ltd 0.00% New 24 $338
Osaic Holdings, Inc. 0.00% Reduce -99.9% 10 $140
Allworth Financial LP 0.00% No change 1 $15

"% of holder's portfolio" is KZIA's weight in each manager's 13F, not the share of Kazia Therapeutics-Spon ADR the manager owns.